| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |